0001209191-22-051947.txt : 20221003 0001209191-22-051947.hdr.sgml : 20221003 20221003182614 ACCESSION NUMBER: 0001209191-22-051947 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220929 FILED AS OF DATE: 20221003 DATE AS OF CHANGE: 20221003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RINGOLD GORDON CENTRAL INDEX KEY: 0001101713 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39488 FILM NUMBER: 221288972 MAIL ADDRESS: STREET 1: 325 EAST MIDDLEFIELD AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apexigen, Inc. CENTRAL INDEX KEY: 0001814140 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851260244 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 SHOREWAY ROAD, SUITE C CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650.931.6236 MAIL ADDRESS: STREET 1: 75 SHOREWAY ROAD, SUITE C CITY: SAN CARLOS STATE: CA ZIP: 94070 FORMER COMPANY: FORMER CONFORMED NAME: Brookline Capital Acquisition Corp. DATE OF NAME CHANGE: 20200603 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-09-29 0 0001814140 Apexigen, Inc. APGN 0001101713 RINGOLD GORDON C/O APEXIGEN, INC. 75 SHOREWAY ROAD, SUITE C SAN CARLOS CA 94070 1 0 0 0 Stock Option (right to buy) 2.65 2022-09-29 4 A 0 100000 0.00 A 2032-09-29 Common Stock 100000 100000 D The shares subject to the option vest in three equal annual installments beginning on July 29, 2023. /s/ Francis Sarena, by power of attorney 2022-10-03